​We are driven by our vision to open new treatment pathways by developing targeted drugs for debilitating diseases.

Alexander Belcredi, MBA

CEO Business & Finance

Dr. Lorenzo Corsini

CEO Research & Development

Dr. Albina Poljak

Director Business Development

Dr. Michele Mutti

Research Lead

Vera Oberbauer, MSc.

Researcher

Marcela Restrepo, MSc.

Senior Researcher

Dr. Lenka Tišáková

Phage Research Lead

Dr. Zehra Visram

Phage Research Lead

Timo Schwebs, MSc.

Researcher

Dr. Nel Moore, Board Chair

Bettina Goerner

Dr. Judith Kölzer-Söding

Gerd Wübbels